A molecular target particularly suitable for TRT of GBM is the neurokinin-1 receptor (NK1R) [4], since it was shown to be widely overexpressed in GBM as well as in many grade II and grade III gliomas [5]. This evidence concerns the gene TACR1 and glioblastoma.